Measuring information quality serves as gateway to IT success
The ability to generate quality information is the one factor in an IT system that can improve medical care, tackle supplier integration, and convince physicians to buy into the use of IT, according to a triumvirate of experts presenting at HIMSS09. But while quality information is the obvious goal of healthcare IT, the means for achieving it is anything but.
The ability to generate quality information is the one factor in an IT system that can improve medical care, tackle supplier integration, and convince physicians to buy into the use of IT, according to a triumvirate of experts presenting at HIMSS09. But while quality information is the obvious goal of healthcare IT, the means for achieving it is anything but.
Specifically at issue is the technology for determining what is “quality information.” Only by developing and implementing effective means to measure this quality can the operators of healthcare IT have a means for assessing the IT itself.
Dr. David Reiter of Jefferson Medical College and Dr. Eugene S. Schneller of Arizona State University joined with Randy L. Thomas, vice president of Integrated Product Management and Marketing at Premier, to argue that value analysis techniques can be harnessed to ensure quality information. Any of several metrics might be applied. The one common denominator is the end result, specifically the output of reliable and applicable data.
Winning physician “buy-in” to healthcare IT is a major reason behind the effort to develop these metrics and the quality information they breed, the presenters said. Quality information empowers physicians by identifying opportunities for improved care. There are other benefits as well, specifically that quality information can be used to improve the integration of suppliers, as it indicates where and how suppliers can work more effectively.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
